| Literature DB >> 23299102 |
Bryan Anthony Pukenas1, Monisha Kumar, Michael Stiefel, Michelle Smith, Robert Hurst.
Abstract
Dural venous sinus thrombosis is a rare and potentially devastating disease. Several predisposing factors exist, including oral contraceptive therapy and colitis. First-line therapy consists of systemic anticoagulation. If first-line therapies fail, more aggressive endovascular therapies may be performed. We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus thrombosis.Entities:
Keywords: Brain; Intervention; Stent; Thrombectomy; Vein
Mesh:
Year: 2013 PMID: 23299102 DOI: 10.1136/neurintsurg-2012-010543.rep
Source DB: PubMed Journal: J Neurointerv Surg ISSN: 1759-8478 Impact factor: 5.836